What are the recommended antihypertensive treatment options and the common adverse effects of the major blood pressure medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blood Pressure Medications: First-Line Treatment and Common Side Effects

For adults with hypertension requiring pharmacological treatment, start with thiazide/thiazide-like diuretics, ACE inhibitors (in non-Black patients), ARBs, or long-acting calcium channel blockers as first-line monotherapy, or use combination therapy with two of these agents if BP is ≥20/10 mmHg above target. 1

First-Line Antihypertensive Drug Classes

The most recent WHO 2022 guidelines 1 and multiple international guidelines 2, 3, 4 establish four primary drug classes as first-line therapy:

Thiazide and Thiazide-Like Diuretics

  • Strongest evidence for mortality reduction (11.0% control vs 9.8% treatment; RR 0.89) 5
  • Reduce stroke by 32% and total cardiovascular events by 30% 5
  • Preferred for isolated systolic hypertension 2, 3
  • Thiazide-like agents (chlorthalidone, indapamide) may offer superior cardiovascular protection compared to hydrochlorothiazide 6

ACE Inhibitors

  • Reduce mortality by 17%, stroke by 35%, and coronary heart disease by 19% 5
  • Not recommended as first-line in Black patients (Grade A) 2, 3
  • Preferred in patients with diabetes, heart failure, or post-MI 7

Angiotensin Receptor Blockers (ARBs)

  • Similar organ-protective effects to ACE inhibitors 7
  • Better tolerated than ACE inhibitors (no cough) 8
  • Combination of ACE inhibitor + ARB is NOT recommended (Grade A) 2, 3

Long-Acting Calcium Channel Blockers

  • Reduce stroke by 42% and total cardiovascular events by 29% 5
  • Particularly effective in isolated systolic hypertension 2, 3
  • Dihydropyridines (amlodipine, nifedipine) preferred over non-dihydropyridines

Beta-Blockers: Limited First-Line Role

Beta-blockers are NOT recommended as first-line therapy for uncomplicated hypertension in patients ≥60 years old (Grade A) 2, 3. They should be reserved for:

  • Patients <60 years with uncomplicated hypertension 2, 3
  • Compelling indications: post-MI, angina, heart failure, atrial fibrillation 4, 9

Combination Therapy Strategy

Most patients require ≥2 drugs to achieve target BP 10, 11. The WHO recommends combination therapy, preferably as single-pill combinations, for initial treatment 1:

Preferred Combinations (Grade B-C):

  • ACE inhibitor or ARB + calcium channel blocker
  • ACE inhibitor or ARB + thiazide/thiazide-like diuretic
  • Calcium channel blocker + thiazide/thiazide-like diuretic

Combinations to Avoid:

  • Non-dihydropyridine CCB + beta-blocker (caution, Grade D) 2, 3
  • ACE inhibitor + ARB (not recommended, Grade A) 2, 3

Start with combination therapy immediately if SBP is ≥20 mmHg or DBP is ≥10 mmHg above target, but exercise caution in elderly or frail patients 2, 3.

Common Adverse Effects by Drug Class

Thiazide/Thiazide-Like Diuretics

  • Hypokalemia (must be avoided, Grade C) 2, 3
  • Hyperuricemia and gout
  • Glucose intolerance and new-onset diabetes
  • Hyponatremia
  • Withdrawal rate: 11.3% vs 5.0% placebo (RR 2.38) 5

ACE Inhibitors

  • Dry cough (most common, 5-20% of patients) 8
  • Angioedema (rare but serious)
  • Hyperkalemia (monitor in renal impairment)
  • Acute kidney injury (particularly with bilateral renal artery stenosis)
  • Contraindicated in pregnancy

ARBs

  • Better tolerated than ACE inhibitors (no cough) 8
  • Hyperkalemia
  • Dizziness
  • Acute kidney injury (same precautions as ACE inhibitors)
  • Contraindicated in pregnancy

Calcium Channel Blockers

  • Peripheral edema (especially with dihydropyridines)
  • Headache
  • Flushing
  • Constipation (particularly with non-dihydropyridines like verapamil)
  • Gingival hyperplasia

Beta-Blockers

  • Highest withdrawal rate: 14.4% vs 3.1% placebo (RR 4.59) 5
  • Fatigue and exercise intolerance
  • Bradycardia
  • Bronchospasm (avoid in asthma/COPD)
  • Sexual dysfunction
  • Masking of hypoglycemia symptoms
  • Metabolic effects (glucose intolerance, dyslipidemia)

Resistant Hypertension Management

If BP remains uncontrolled on 2-3 first-line agents 2, 3:

  1. Add spironolactone 25-50 mg/day (reduces SBP by 6.6-8.7 mmHg, superior to doxazosin or bisoprolol) 6
  2. If spironolactone not tolerated (hyperkalemia in 4-40%, antiandrogenic effects):
    • Consider eplerenone, amiloride, doxazosin, clonidine, or beta-blocker 4, 6
  3. Screen for secondary hypertension causes 6
  4. Assess medication adherence and lifestyle factors 2, 3

Critical Pitfalls to Avoid

  • Do not use high-dose thiazides: High-dose thiazides do not reduce mortality (RR 0.90) and have worse side effects than low-dose 5
  • Avoid hypokalemia with diuretic monotherapy: Monitor potassium and supplement or use potassium-sparing agents 2, 3
  • Monitor renal function and potassium when using ACE inhibitors/ARBs, especially with eGFR <45 mL/min/1.73 m² 6
  • Do not delay treatment for extensive testing: Start treatment promptly; testing should not impede initiation 1
  • Caution in elderly/frail patients: Start lower doses and titrate carefully to avoid hypotension 2, 3

Target Blood Pressure

Target BP <140/90 mmHg for all patients with hypertension 1. Target SBP <130 mmHg for high-risk patients (existing CVD, diabetes, CKD) 1, 4. Achieve target within 3 months with monthly follow-up 1.

References

Research

First-line drugs for hypertension.

The Cochrane database of systematic reviews, 2018

Guideline

east meets west: bringing the esh 2023 hypertension guidelines into asia.

European journal of internal medicine, 2024

Related Questions

What are the most effective oral medications to lower systolic blood pressure?
What is the recommended order of antihypertensive medication classes based on their classification and specific indications?
What is the recommended order of prescribing antihypertensive medications based on drug class and clinical indication, and what are the contraindications for each class?
If 100 mL of normal saline is to be infused over 25 minutes and 1 mL equals 20 drops, what is the drop rate per minute?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate management of acute hepatitis A, B, and C, including recommended medications, dosages, routes of administration, side effects, and contraindications?
In a 70-year-old patient with increased urinary frequency, a magnetic gait, and dementia, what is the most likely diagnosis and appropriate next diagnostic and therapeutic steps?
What are the step‑by‑step management steps for a patient presenting with an acute abdomen requiring surgical intervention?
In a 70-year-old patient presenting with magnetic gait, urinary frequency, and dementia consistent with normal-pressure hydrocephalus, is levodopa indicated?
What is the recommended fluid resuscitation protocol, including volume and infusion duration, for a 25-year-old man?
Are routine pre‑operative diagnostic tests considered standard of care for surgical patients aged 65 years and older?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.